About INTOX lab
INTOX lab is a company based in Pune (India) founded in 1995 was acquired by Aragen in December 2021. The company has 118 employees. INTOX lab offers products and services including Analytical Chemistry, General Toxicology, Clinical Bioanalysis, and Environmental Toxicology. INTOX lab operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
- Headquarter Pune, India
- Employees 118
- SectorsHealthcare
- Email••••••••
- Website intoxlab.com
- Social LinkedIn X
- Acquired by Aragen (Dec 2021)
- Legal Name Intox Private Limited
- Date of Incorporation 17 Jul, 2000
- Jurisdiction Mulshi, Maharashtra, India
- Annual Revenue₹45.44 Cr
FY 2025 · -20% YoY
- Net Profit₹5.88 Cr
FY 2025 · 13% margin
- EBITDA₹11.83 Cr
FY 2025 · 26% margin
- Investors
- Employee Count118
- Acquired byAragen
(Dec 2021)
Associated legal entities of INTOX lab
INTOX lab operates through Intox Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Intox Private Limited CIN U74999PN2000PTC015116 | Active | 17 Jul 2000 | Mulshi, Maharashtra | ₹45.4 Cr | 118 | 5 | View details |
Products & Services of INTOX lab
INTOX lab offers a comprehensive portfolio of products and services, including Analytical Chemistry, General Toxicology, Clinical Bioanalysis, and Environmental Toxicology.
Conducts impurity profiling and chemical analysis for various molecules.
Performs in vivo and in vitro studies for product safety evaluation.
Supports clinical trials with pharmacokinetics and immunogenicity analysis.
Assesses risks and hazards of compounds on ecosystems.
Investors in INTOX lab
INTOX lab has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aragen Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals. | 2001 | aragen.com | Hyderabad, India |
Investor details for INTOX lab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Intox Private Limited (INTOX lab)
Intox Private Limited is the primary company behind INTOX lab. The board of Intox Private Limited currently have 4 directors; the longest-serving is Ajay Srivastava, appointed in 2021. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajay Srivastava DIN 00049912 | Director | 13 Dec 2021 | 4 yrs 9 mo | Intox Private Limited |
| Mukul Prabhakar Pore DIN 01684756 | Director | 09 Dec 2022 | 3 yrs 10 mo | Intox Private Limited |
| Manmahesh Kantipudi DIN 05241166 | Director | 25 Apr 2023 | 3 yrs 5 mo | Intox Private Limited |
| Narendra Sampatrao Deshmukh DIN 00789947 | Director | 15 Dec 2023 | 2 yrs 9 mo | Intox Private Limited |
Financials of INTOX lab
Figures of Intox Private Limited, the primary company behind INTOX lab, for FY 2025. Revenue was ₹45.44 Cr (-20% year on year). Net profit was ₹5.88 Cr (13% margin). EBITDA was ₹11.83 Cr (26% margin). Revenue has grown at a compounded annual rate of -12% over three years and +13% over five years.
- ₹45.44 CrRevenue · FY 2025 · -20% YoY
- ₹5.88 CrNet profit · 13% margin
- ₹11.83 CrEBITDA · 26% margin
- ₹76 LakhPaid-up capital
- 118Employees (provident fund records)
- -12%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Intox Private Limited are on its company page.
Detailed financial statements for INTOX lab
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of INTOX lab
2 dated milestones of INTOX lab across 26 years, from founding to its latest funding, stage changes and deals.
- Founded INTOX lab is founded.
- Exit Acquired by Aragen.
Competitors of INTOX lab
INTOX lab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gentronix.co.uk | 1999 | Alderley Edge, United Kingdom | $3.84M | 1 | In-vitro and in-vivo genetic toxicology screening services are provided. | |
| tigermedgrp.com | 2004 | Hangzhou, China | – | 15 | Drug development and preclinical services are provided by Tigermed. | |
| simrbio.com | 2014 | Shanghai, China | $20.76M | – | Diversified preclinical services for brain-related disorders are provided. | |
| gubra.dk | 2008 | Horsholm, Denmark | – | – | Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided. | |
| bioqual.com | 1981 | Rockville, United States | – | 193 | Contract research on infectious disease models is conducted. | |
| aquila-bm.com | 2011 | Edinburgh, United Kingdom | – | 489 | Preclinical services in immunology, regeneration, neuroscience, and histology are provided. | |
| phaxiam.com | 2004 | Lyon, France | $15.8M | – | Antibacterial treatments using bacteriophages are developed for resistant infections. | |
| vgxii.com | 1997 | The Woodlands, United States | – | – | Contract developer and manufacturer of plasmids | |
| reveragen.com | 2008 | Rockville, United States | – | – | Steroids for Duchenne muscular dystrophy treatment are developed. |
Detailed competitors of INTOX lab
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of INTOX lab
The website of INTOX lab (intoxlab.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 34.6% vs previous month
Websites whose visitors overlap most with INTOX lab. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
huntingdon.com | huntingdon.com | 100% | – | – | – |
| biotestlab.de | 100% | – | – | View details | |
mbresearch.com | mbresearch.com | 100% | – | #13,344,910 | – |
| mpiresearch.com | 100% | – | – | View details | |
| rajbiotech.com | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for INTOX lab
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Intox Lab
Complete news archive for INTOX lab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to INTOX lab
10 companies that operate in the same segment as INTOX lab (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about INTOX lab
INTOX lab was founded in 1995.
INTOX lab is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
INTOX lab has 118 employees.
The primary company behind INTOX lab, Intox Private Limited, reported revenue of ₹45.44 Cr for FY 2025, down 20% year on year.
Founded in 1995 and based in Pune, India, INTOX lab operates in the preclinical services sector. Contract research services are provided to domestic and international clients, encompassing toxicology, eco-toxicology, mutagenicity, and analytical chemistry. Test programs are developed to meet product registration requirements aligned with standards from OECD, USFDA, EMEA, ICH, EC, ISO, USP, DCGI, DBT, and CIB. Studies include general toxicity, reproductive toxicity, genetic toxicity, environmental toxicity, and biocompatibility assessments.
INTOX lab offers Analytical Chemistry, General Toxicology, Clinical Bioanalysis, and Environmental Toxicology.
INTOX lab has 1 investor. Key investors include Aragen Life Sciences.
INTOX lab operates through Intox Private Limited.
Yes. INTOX lab was acquired by Aragen in December 2021.
The legal entities of INTOX lab currently have 5 directors, including Mukul Prabhakar Pore, Ajay Srivastava, Narendra Sampatrao Deshmukh and others.